Community Oncology Research Program
As the first NCORP Community Site within the state of New Jersey, Atlantic Health Cancer Consortium Community Oncology Research Program (AHCC-CORP) combines the collective strengths of world-class health care systems with community oncology care delivery.
An unprecedented collaboration between institutions for the advancement of national research interests in cancer
This program covers an area with diverse geography and demographics, representing approximately 70% of New Jersey’s population. The program expands the NCORP network by 6.5 million people; with a higher cancer incidence rate than the US as a whole (477.5 vs 441.2 cases per 100,000). Regions within the program are even further elevated.
We aim to:
Increase
adult and pediatric accruals to National Cancer Institute in cancer prevention, control, screening, and care delivery research studies, as well as treatment and imaging studies conducted by the National Clinical Trials Network and biospecimen collection.
Enhance
community engagement in cancer control and prevention clinical trials and Cancer Care Delivery Research (CCDR) conducted by NCORP in the program region. CCDR is a science that seeks to improve clinical outcomes and patient well-being by intervening on patient, clinician, and organizational factors that influence care delivery.
Contribute
to the development and implementation of clinically significant studies that incorporate the unique research needs of the diverse population within the program service area, leveraging the expertise of established oncology specialty physicians and other providers within our affiliate network.
Our members:
Baseline enrollment data for our first year has demonstrated considerable diversity in NCI trial participants
- Over 40% of our enrollment has been from pediatric, adolescent and young adult populations.
- Over 30% of our enrollment has been from a non-White population, reflecting the multicultural diversity in the state.